The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.
NYS Entity Status
NYS Filing Date
JULY 07, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - L AND L PROPERTY MANAGEMENT LLC
AROUND THE WEB
- Shareholders Demand More Drastic Shifts at Nestlé
By STEPHANIE STROM - Tuesday Jun 27, 2017
- Third Point, a Hedge Fund, Sets Its Activist Sights on Nestlé
By MICHAEL J. de la MERCED - Sunday Jun 25, 2017
The fund, run by Daniel S. Loeb, has called on the Swiss food giant to sell its stake in L’Oréal and move more quickly to adapt to changing consumer tastes.
- Cyprexx, Prempoint Launch Innovative Entry Management System
By Business Wire - Thursday Sep 14, 2017
PRESS RELEASE: Cyprexx Services, LLC in partnership with Prempoint Inc. will be launching a new entry management system in Fall 2017. Lockwise™ is a new keyless entry management system that allows property access to be granted digitally. This device...
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Trump’s Tough Talk on North Korea Puts Japan’s Leader in Delicate Spot
By JONATHAN SOBLE - Friday Aug 11, 2017
North Korea’s accelerating military advances — and President Trump’s volatile response — could complicate Japan’s close alliance with the United States.
- Former monk sues L’Oreal over antiaging formula
By Pat Eaton-Robb - Wednesday Aug 30, 2017
A former Roman Catholic monk has filed a federal lawsuit seeking unspecified damages against cosmetics giant L’Oreal, accusing the company of stealing patented technology in an antiaging wrinkle cream that his charity was selling to raise money for the poor. Dennis Wyrzykowski and his company, Carmel Laboratories LLC, have been joined in the lawsuit by the University of Massachusetts Medical School, which developed the technology and licensed it to Carmel in 2009. According to the lawsuit, the cream, called Easeamine, is made using technology inspired by a discovery by two UMass scientists that adenosine, a chemical compound found in the heart, can promote skin elasticity.